Twist Bioscience Corporation
TWST
주식 순위
#2144
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
주가
$144.87
시가총액
$9.54B
변동 (1일)
3.65%
변동 (1년)
342.47%
국가
US
거래 Twist Bioscience Corporation (TWST)
카테고리
Healthcare
Twist Bioscience Corporation (TWST)의 발행 주식 수
June 2026 기준 발행 주식 수: 62.40M
Twist Bioscience Corporation의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 62.40M입니다. September 2024 말 기준 회사는 58.02M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Twist Bioscience Corporation (TWST)의 발행 주식 수 기록 (2016 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2026 (TTM) | 62.40M | 4.34% |
| 2025 | 59.81M | 3.09% |
| 2024 | 58.02M | 1.99% |
| 2023 | 56.89M | 5.57% |
| 2022 | 53.89M | 11.68% |
| 2021 | 48.25M | 23.12% |
| 2020 | 39.19M | 42.71% |
| 2019 | 27.46M | 3.20% |
| 2018 | 26.61M | 41.69% |
| 2017 | 18.78M | 0.00% |
| 2016 | 18.78M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 371.00M | 494.52% |
US
|
|
| 705.30M | 1,030.23% |
US
|
|
| 143.28M | 129.60% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 351.90% |
US
|
